[Stress protection therapy in the prevention of macular morphological lesions in patients with diabetes mellitus at cataract microsurgery].
Patients with a family history of diabetes mellitus should undergo complex antistress protection of the macula for the prevention of its stress-induced lesions during cataract phacoemulsification with intraocular lens implantation. A differential algorithm of stress protection therapy has been developed in relation to the phase of surgical stress, the use of which is to enhance the tolerance of vegetovascular, hemodynamic, and metabolic systems to the aggressive components of surgical stress, thus reducing the incidence of transient subclinical and clinical macular edema.
Egorov
V V
VV
Egorova
A V
AV
Smoliakova
G P
GP
Utkin
S I
SI
D000368:Aged; D002331:Carnitine / Q000008:administration & dosage / Q000627:therapeutic use*; D004247:DNA / Q000008:administration & dosage / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000601:surgery*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006439:Hemodynamics; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D019654:Lens Implantation, Intraocular / Q000379:methods; D008266:Macula Lutea / Q000473:pathology*; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D018918:Phacoemulsification / Q000379:methods*; D011183:Postoperative Complications / Q000097:blood / Q000503:physiopathology / Q000517:prevention & control*; D012307:Risk Factors; D013312:Stress, Physiological; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000627:therapeutic use
C541364:Derinat; D014803:Vitamin B Complex; D004247:DNA; D002331:Carnitine; D006854:Hydrocortisone